As filed with the Securities and Exchange Commission on July 24, 2019 Registration...
A New Beginning neuralstem.com Issuer Free Writing Prospectus Filed Pursuant to Rule 433 Dated July...
As filed with the Securities and Exchange Commission on July 22, 2019 Registration...
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ...
Neuralstem Appoints Mary Ann Gray, Ph.D., to Board of Directors PR Newswire GERMANTOWN, Md., July 18, 2019 GERMANTOWN, Md., July 18, 2019...
Neuralstem Announces a 1-for-20 Reverse Stock Split PR Newswire GERMANTOWN, Md., July 16, 2019 GERMANTOWN, Md., July 16, 2019 /PRNewswire/...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...
FORM 3 UNITED STATES SECURITIES AND EXCHANGE...
Neuralstem Announces Publication of Results from Phase 1 Clinical Trial Evaluating Human Neural Stem Cells in Chronic Stroke Patients PR...
As filed with the Securities and Exchange Commission on June 21, 2019 Registration No...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.